切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2019, Vol. 15 ›› Issue (05) : 554 -559. doi: 10.3877/cma.j.issn.1673-5250.2019.05.012

所属专题: 文献

论著

妊娠期高血压患者血清微小RNA-210、-204-5p、-376c与其血液流变学指标的相关性及其诊断价值研究
刘杰1,(), 梁玉贞1   
  1. 1. 河北省黄骅市人民医院妇产二科 061100
  • 收稿日期:2019-06-03 修回日期:2019-09-12 出版日期:2019-10-01
  • 通信作者: 刘杰

Correlations between serum microRNA-210, -204-5p, -376c and hemorheology indexes in patients with pregnancy-induced hypertension and their diagnostic values

Jie Liu1,(), Yuzhen Liang1   

  1. 1. Department of Obstetrics and Gynecology, Huanghua Municipal People′s Hospital of Hebei Province, Huanghua 061100, Hebei Province, China
  • Received:2019-06-03 Revised:2019-09-12 Published:2019-10-01
  • Corresponding author: Jie Liu
  • About author:
    Corresponding author: Liu Jie, Email:
  • Supported by:
    Key Science and Technology Research Project of Health Commission of Hebei Province(20191175)
引用本文:

刘杰, 梁玉贞. 妊娠期高血压患者血清微小RNA-210、-204-5p、-376c与其血液流变学指标的相关性及其诊断价值研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2019, 15(05): 554-559.

Jie Liu, Yuzhen Liang. Correlations between serum microRNA-210, -204-5p, -376c and hemorheology indexes in patients with pregnancy-induced hypertension and their diagnostic values[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2019, 15(05): 554-559.

目的

探讨妊娠期高血压患者血清微小RNA(miRNA)-210、-204-5p、-376c与其血液流变学指标的相关性,以及其诊断价值。

方法

采用简单随机抽样方法,随机抽取2016年10月至2018年10月,于河北省黄骅市人民医院收治的妊娠期高血压患者80例为研究对象,并纳入研究组(n=80)。采用相同抽样方法,随机抽取同期于本院接受定期产前检查的80例中孕期正常妊娠妇女为对照,纳入对照组(n=80)。采用实时荧光定量PCR,检测2组受试者血清miRNA-210、-204-5p及-376c的相对表达量。采用全自动血细胞分析仪,检测2组受试者的血液流变学指标。2组受试者血清miRNA-210、-204-5p、-376c相对表达量及血液流变学指标比较,采用成组t检验。采用受试者工作曲线下面积(ROC-AUC),分析血清miRNA-210、-204-5p及-376c的相对表达量,对妊娠期高血压的诊断价值。采用Pearson相关系数分析妊娠期高血压患者血清miRNA-210、-204-5p及-376c的相对表达量与其血液流变学指标的相关性。本研究获得河北省黄骅市人民医院伦理委员会批准(批准文号:18101523),并且受试者均签署临床研究知情同意书。2组受试者的年龄、入组时孕龄、孕前人体质量指数、孕次、产次等一般临床资料分别比较,差异均无统计学意义(P>0.05)。

结果

①研究组患者血清miRNA-210、-204-5p的相对表达量分别为(1.56±0.35)与(1.78±0.40),均显著高于对照组的(0.59±0.11)与(0.72±0.15),研究组患者血清miRNA-376c的相对表达量为(0.33±0.09),却显著低于对照组的(1.24±0.32),2组上述指标分别比较,差异均有统计学意义(t=23.648、22.193、24.485,均为P<0.001)。②血清miRNA-210、-204-5p及-376c的相对表达量诊断妊娠期高血压的ROC-AUC分别为0.824(95%CI:0.738~0.902,P<0.001),0.871(95%CI:0.810~0.943,P<0.001),0.833(95%CI:0.746~0.908,P<0.001)。根据约登指数最大原则,血清miRNA-210、-204-5p及-376c的相对表达量,对于诊断妊娠期高血压的最佳临界值分别为0.696、1.512及0.712,此时其诊断妊娠期高血压的敏感度分别为83.3%、93.1%及85.0%,特异度分别为85.0%、75.0%及85.0%。③研究组患者的全血低切黏度(WRV)、低切还原黏度(LSRV)、血浆黏度(PV)分别为(7.9±1.5) mPa·s、(17.6±3.6) mPa·s、(1.6±0.3) mPa·s,分别显著高于对照组的(7.2±1.3) mPa·s、(15.6±3.4) mPa·s、(1.2±0.2) mPa·s,2组上述指标比较,差异均有统计学意义(t=3.154、P=0.002,t=3.613、P<0.001,t=9.923、P<0.001)。④妊娠期高血压患者血清miRNA-210相对表达量与其WRV、LSRV、PV,均呈正相关关系(r=0.343、P=0.002,r=0.415、P<0.001,r=0.287,P=0.001);血清miRNA-204-5p相对表达量与PV亦呈正相关关系(r=0.326、P=0.003);miRNA-376c相对表达量与WRV、LSRV,均呈正相关关系(r=0.317、P=0.004,r=0.351、P=0.001)。

结论

妊娠期高血压患者血清miRNA-210、-204-5p、-376c相对表达量与其血液流变学指标存在相关性,并且有望成为诊断妊娠期高血压的潜在生物标志物。

Objective

To investigate correlations between serum microRNA (miRNA)-210, -204-5p, -376c and hemorheology indexes in patients with pregnancy-induced hypertension and their diagnostic values.

Methods

Eighty patients with pregnancy-induced hypertension admitted in Huanghua Municipal People′s Hospital of Hebei Province from October 2016 to October 2018 were randomly selected as research subjects by simple random sampling method and enrolled into study group (n=80). And 80 normal pregnant women in the second trimester were randomly selected by the same method during the same period in the same hospital as control group (n=80). Real-time quantitative PCR was used to detect relative expression levels of serum miRNA-210, -204-5p, -376 of two groups. Hemorheology indexes were measured in two groups of subjects by automatic blood cell analyzer. Independent-samples t test was used to compare the relative expression levels of serum miRNA-210, -204-5p, -376 and hemorheology indexes between two groups. Area under receiver operating characteristic curve (ROC-AUC) was used to analyze the diagnostic values of relative expression levels of serum miRNA-210, -204-5p, -376 in diagnosis of pregnancy-induced hypertension. Pearson correlation coefficient was used to analyze the correlation between expression levels of serum miRNA-210, -204-5p and -376c and hemorheology indexes in patients with pregnancy-induced hypertension. This study was approved by the Ethics Committee of Huanghua Municipal People′s Hospital of Hebei Province (Approval No. 18101523). Clinical research informed consent was obtained from each participate. There were no statistical differences in the general clinical data such as age, gestational age at the time of enrollment, body mass index before pregnancy, gravidity, parity of patients, and so on (P>0.05).

Results

①The relative expression levels of serum miRNA-210 and miRNA-204-5p in study group were (1.56±0.35) and (1.78±0.40), respectively, which were higher than those (0.59±0.11), (0.72±0.15) in control group, respectively, and relative expression level of serum miRNA-376c in study group was (0.33±0.09), which was lower than that (1.24±0.32) in control group, and all the differences between two groups were statistically different (t=23.648, 22.193, 24.485; all P<0.001). ②The ROC-AUC of relative expression levels of serum miRNA-210, -204-5p, and -376c in diagnosis of pregnancy-induced hypertension were 0.824 (95%CI: 0.738-0.902, P<0.001), 0.871 (95%CI: 0.810-0.943, P<0.001), 0.833 (95%CI: 0.746-0.908, P<0.001), respectively. According to the maximum principle of Youden index, the optimal cut-off values of relative expression levels of serum miRNA-210, -204-5p, and -376c in diagnosis of pregnancy-induced hypertension were 0.696, 1.512, and 0.712, respectively. And the sensitivities for diagnosis of pregnancy-induced hypertension were 83.3%, 93.1% and 85.0%, respectively, and the specificities were 85.0%, 75.0% and 85.0%, respectively. ③The wholeblood reduced viscosity (WRV), low shear reduction viscosity (LSRV) and plasma viscosity (PV) of patients with pregnancy-induced hypertension in study group were (7.9±1.5) mPa·s, (17.6±3.6) mPa·s, (1.6±0.3) mPa·s, respectively, which were higher than those (7.2±1.3) mPa·s, (15.6±3.4) mPa·s, (1.2±0.2) mPa·s of healthy pregnant women in control group, respectively, and all the differences were statistically significant (t=3.154, P=0.002; t=3.613, P<0.001; t=9.923, P<0.001). ④There was a positive correlation between relative expression levels of serum miRNA-210 and WRV, LSRV and PV, respectively (r=0.343, P=0.002; r=0.415, P<0.001; r=0.287, P=0.001). There was a positive correlation between relative expression levels of serum miRNA-204-5p and PV (r=0.326, P=0.003). There was a positive correlation between relative expression levels of serum miRNA-376c and WRV, LSRV, respectively (r=0.317, P=0.004; r=0.351, P=0.001).

Conclusions

Relative expression levels of serum miRNA-210, miRNA-204-5p and miRNA-376c are associated with hemorheology indexes, and can be used as potential biomarkers for the diagnosis of pregnancy-induced hypertension, perhaps.

表1 2组受试者血清miRNA-210、-204-5p及-376c的相对表达量比较(±s)
表2 2组受试者血清miRNA-210、-204-5p及-376c的相对表达量诊断妊娠期高血压的ROC曲线分析结果
图1 2组受试者血清miRNA-210、-204-5p及-376c的相对表达量诊断妊娠期高血压的ROC曲线
表3 2组受试者血液流变学指标比较(±s)
[1]
高丽钦,陈惠娟,陈小琦,等. 血栓弹力图分析在妊娠高血压综合征中的应用价值[J]. 中华高血压杂志,2018, 26(12): 1177-1181.
[2]
张红,赵红美. 重度妊娠高血压综合征患者分娩时机及方式对母婴安全影响[J]. 社区医学杂志,2018, 16(14): 1163-1165.
[3]
Dragomir MP, Knutsen E, Calin GA. SnapShot: unconventional miRNA functions[J]. Cell, 2018, 174(4): 1038-1038.e1.
[4]
Fu G, Ye G, Nadeem L, et al. MicroRNA-376c impairs transforming growth factor-β and nodal signaling to promote trophoblast cell proliferation and invasion[J]. Hypertension, 2013, 61(4): 864-872.
[5]
Mei ZX, Huang BQ, Mo Y, et al. An exploratory study into the role of miR-204-5p in pregnancy-induced hypertension[J]. Exp Ther Med, 2017, 13(5): 1711-1718.
[6]
Biró O, Alasztics B, Molvarec A, et al. Various levels of circulating exosomal total-miRNA and miR-210 hypoxamiR in different forms of pregnancy hypertension[J]. Pregnancy Hypertens, 2017, 10(10): 207-212.
[7]
中华医学会妇产科学分会妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2015)[J]. 中华妇产科杂志,2015, 50(10): 721-728.
[8]
Ding C, He J, Liao W, et al. Regulation of WNT/β-catenin signaling by carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (CAD) in colorectal cancer cell[J]. Int J Clin Exp Med, 2017, 10(12): 16243-16253.
[9]
Butalia S, Audibert F, Côté AM, et al. Hypertension Canada′s 2018 guidelines for the management of hypertension in pregnancy[J]. Can J Cardiol, 2018, 34(5): 526-531.
[10]
孙艳华. 妊娠高血压疾病患者血液流变学凝血和纤溶系统指标检测的临床意义[J]. 河北医学,2018, 24(9): 1557-1561.
[11]
李玉霞,柯鑫,纪泽虹. 早期护理干预对妊娠高血压轻度子痫前期患者血压与24 h尿蛋白的影响[J]. 护理实践与研究,2017, 14(9): 73-74.
[12]
Lu A, Disoma C, Zhou YZ, et al. Protein interactome of the deamidase phosphoribosylformylglycinamidine synthetase (PFAS) by LC-MS/MS[J]. Bioche Biophys Res Commun, 2019, 513(3): 746-752.
[13]
Liu Y, Wang F, Liu P, et al. MicroRNA-214-3p in the kidney contributes to the development of hypertension[J]. J Am Soc Nephrol, 2018, 29(10): 2518-2528.
[14]
Yang H, Zhang H, Meng F, et al. Differential expression of microRNA-411 and 376c is associated with hypertension in pregnancy[J]. Braz J Med Biol Res, 2019, 52(4): e7546.
[15]
曾军. MiR-204-5p/Six1反馈调控乳腺癌细胞表皮间质转化的机制研究[D]. 广州:南方医科大学,2016.
[16]
余梓浦. miR-204-5p抑制非小细胞肺癌生长的作用及分子机制研究[D]. 杭州:浙江大学,2016.
[17]
Késmárky G, Kenyeres P, Rábai M, et al. Plasma viscosity: a forgotten variable[J]. Clin Hemorheol Microcirc, 2008, 39(1-4): 243-246.
[18]
Cusumano P, Biscontin A, Sandrelli F, et al. Modulation of miR-210 alters phasing of circadian locomotor activity and impairs projections of PDF clock neurons in Drosophila melanogaster[J]. PLos Genet, 2018, 14(7): e1007500.
[19]
黎玉涵,孙小丽,罗喜平. 血清微小RNA在恶性肿瘤临床应用中的研究进展[J/CD]. 中华妇幼临床医学杂志(电子版), 2015, 11(1): 95-98.
[20]
何少仪,孙小丽,罗喜平. 血清microRNA在妇科恶性肿瘤临床诊断及其预后评价中的研究进展[J/CD]. 中华妇幼临床医学杂志(电子版), 2015, 11(6): 789-792.
[21]
Mazzone AL, Baker RA, McNicholas K, et al. Circulating and urinary miR-210 and miR-16 increase during cardiac surgery using cardiopulmonary bypass: a pilot study[J]. J Extra Corpor Technol, 2018, 50(1): 19-29.
[22]
Luo RC, Shao X, Xu P, et al. MicroRNA-210 contributes to preeclampsia by downregulating potassium channel modulatory factor 1[J]. Hypertension, 2014, 64(4): 839-845.
[1] 钱警语, 郑明明. 《2024意大利妇产科学会非侵入性和侵入性产前诊断指南》解读[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 486-492.
[2] 黄蓉, 梁自毓, 祁文瑾. NLRP3炎症小体在胎膜早破孕妇血清中的表达及其意义[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 540-548.
[3] 何霞, 黄蓉, 祁文瑾. 胎膜早破孕妇胎盘与胎膜菌群丰度的高通量测序研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 549-555.
[4] 谢江燕, 王亚菲, 贺芳. 妊娠合并血栓性血小板减少性紫癜2例并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 556-563.
[5] 韩肖燕, 杨桦. 中孕期孕妇血清胎盘生长因子水平低与胎儿不良预后的关系[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 398-402.
[6] 杜佳丽, 鲍睿, 乔春红, 韩伟. 中孕期宫颈功能不全孕妇经阴道紧急宫颈环扎术后不良妊娠结局预测模型构建[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 403-409.
[7] 徐婷婷, 詹泳池, 王晓东, 刘兴会. 电子胎心监测结果出现正弦波形的胎母输血综合征围生期结局分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 382-389.
[8] 谭娟, 谭建新, 邵彬彬, 王艳, 许争峰. 胎儿单基因遗传病无创产前检测的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 245-250.
[9] 魏艺, 周羽西, 杨烨, 凌秀凤, 赵纯. 微小RNA对子宫内膜容受性影响的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 266-270.
[10] 林雪, 陈锰, 杨梅琳, 刘兴会, 周红雨. 妊娠合并重症肌无力患者的围产结局和重症肌无力病情恶化的影响因素分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 125-132.
[11] 陈义思, 梁敏, 李红雨, 夏雪, 刘燕茜, 李晨曲, 王丹. 妊娠合并慢性肾病围产期多学科团队管理价值研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 133-139.
[12] 贾赛君, 张英, 万佳义. 妊娠合并亚临床甲状腺功能减退孕妇的妊娠结局[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 140-147.
[13] 刘轩瑶, 赵晓曦. 孕妇常见产前筛查指标单独及联合检测对胎儿染色体异常的预测价值[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(06): 657-664.
[14] 陈甜甜, 王晓东, 余海燕. 双胎妊娠合并Gitelman综合征孕妇的妊娠结局及文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 559-568.
[15] 居晓庆, 金蕴洁, 王晓燕. 剖宫产术后瘢痕子宫患者再次妊娠阴道分娩发生子宫破裂的影响因素分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 575-581.
阅读次数
全文


摘要